Advisory Board July 10, 2023
A new vaccine recently approved by FDA to protect against respiratory syncytial virus (RSV) means Americans will have three vaccines available to them — flu, COVID-19, and RSV — to prevent a “tripledemic” of respiratory illnesses in the winter. But experts are concerned vaccine uptake may be challenging.
Can the US avoid a tripledemic?
Last year, the flu may have led to as many as 58,000 deaths, according to CDC, while COVID-19 claimed around 50,000 lives between November and March, and RSV kills up to 10,000 people each year. Only vaccines for the flu and COVID-19 were available last year, but two new vaccines, made by Pfizer and GlaxoSmithKline (GSK), have received FDA approval and CDC recommendation for Americans ages...
Today's Sponsors
Today's Sponsor